Skip to main
Reviews CJC-1295

A scroll-told review of the CJC-1295 research literature — every human pharmacokinetic study, the DAC-versus-no-DAC distinction, and the anti-doping detection record, read in sequence.

What does each study actually tell you?

CJC-1295 research found blood changes, not better health

Work from 2005 through 2025 found hormone changes and ways to detect the drug. It didn't prove a lasting health gain in people.

CJC-1295 stays longer than the hormone it copies

CJC-1295 copies part of a hormone in your body. Your own hormone lasts only minutes. Scientists changed four building blocks so your blood would take longer to clear the drug [2]. The made-in-a-lab copy therefore stays much longer.

The drug reaches your pituitary, the small growth gland near the brain [2]. That gland releases growth hormone in brief rises. Next, the liver raises IGF-1, a growth-related blood reading. Blood tests can show both changes, but not how you feel.

In 2025, a review compared CJC-1295 with two drugs based on the same body hormone [11]. Sermorelin leaves sooner; tesamorelin lasts longer and treats one HIV-associated fat problem. The comparison helps you judge timing, not a gain for healthy people. That limit still applies to you.

Studies in people found higher readings for days

Claims online reach well past the CJC-1295 studies, but work in people mainly measured growth hormone plus IGF-1 and didn't ask how a person's day changed in those small tests. Doctors use that term for a growth-related blood reading. Those readings can't tell you whether daily life changed. For you, the proof stops there.

Researchers gave one shot to healthy adults; it contained 30 or 60 micrograms per kilogram. Average growth hormone in their blood rose 2- to 10-fold and was still high when checked six days later [1]. IGF-1 rose 1.5- to 3-fold for nine to eleven days. After several shots, IGF-1 stayed above the starting level through as many as 28 days.

In another study, healthy young men received one 60 or 90 microgram shot per kilogram. Growth hormone at rest rose about 7.5-fold [3]. At the one-week check, that reading averaged about 46% higher, while IGF-1 averaged about 45% higher. You still don't know what, if anything, the men noticed.

In mice, researchers used 2 micrograms once every 24 hours. These mice couldn't make their own growth message. CJC-1295 brought the mice back to their usual weight and length, but shots every 48-72 hours worked less well [4]. A mouse result can't tell you what your result would be.

Studies in people found higher readings for days

Four findings mark the edge of what we know

If you're sorting CJC-1295 claims, the clearest facts come from blood tests. You can sum up most of that work in four findings. None says you slept better, grew stronger, or became healthier. They report only what the tests found.

First, after an estimated 5.8 to 8.1 days, the attached drug was half gone [1]. Second, IGF-1, a growth-related reading, remained above the start through 28 days after several shots [1]. Third, one shot raised resting growth hormone about 7.5-fold [3]. Fourth, the rats made four times the total amount of growth hormone over time, and the attached drug remained after 72 hours [2].

In 2009, a fat-carrying protein fell, and part of another carrying protein also fell [5]. Pieces of albumin and immune proteins rose as IGF-1 rose. Those changes in IGF-1 may show the drug's growth message reached the body, but they don't tell you anyone felt better. As I size up a claim, I ask whether it goes past these facts.

CJC-1295 with ipamorelin lacks a fair human test

CJC-1295 and ipamorelin are two drugs that act on your growth gland in separate ways [12]. Together, they made that growth gland put out more growth hormone in lab work than either drug did by itself. That finding explains the interest. It doesn't show better health.

Ipamorelin is a made-in-a-lab drug, not a hormone or a message. It prompted growth hormone with little change in cortisol, which helps the body handle stress, or prolactin, which helps make breast milk [12]. Researchers liked that narrow effect. A lab result still won't tell you what a person would feel.

No fair study has tested this pair in healthy adults [12]. We don't know whether it affects sleep, fat, strength, or long-term health. You can see a lab reading rise with both drugs. You still don't have a test of the hoped-for result in people.

Is any CJC-1295 / ipamorelin dose proven?

No study has proved a human dose for this pair. The two drugs act on your growth gland in separate ways. Together, they can release more growth hormone in lab work [12]. Human tests haven't found a safe dose, and CJC-1295 isn't approved medicine.

Has CJC-1295 with ipamorelin helped people?

In lab work, the growth gland released more hormone with the pair than with either drug alone [12]. No fair test has tried the exact pair in healthy adults. A blood change also isn't the same as feeling better. So you don't have proof of a health change anyone noticed.

What does CJC-1295 ipamorelin refer to?

The phrase means using CJC-1295 with ipamorelin, another made-in-a-lab drug. Each drug makes the growth gland respond in its own way. Ipamorelin barely changed two other hormones involved in stress and milk-making [12]. You can't turn that fact into a proved health gain.

CJC-1295 with ipamorelin lacks a fair human test

CJC-1295 has a long form and a short form

Time separates CJC-1295 from two drugs based on the same body hormone. Sermorelin is the shorter drug. Tesamorelin is a steadier drug approved for an HIV-associated fat problem. You can't treat the three drugs as alike just because they share roots.

The long CJC-1295 form stays longest because it fastens to albumin in blood [1][2]. A 2025 review discussed all three drugs together [11]. For your purposes, the key choice is the form of CJC-1295: long or short. Compare how long each form remains.

Sports tests can detect CJC-1295

CJC-1295 is barred in tested sport. Sports labs therefore built tests to find the drug. They can examine blood, urine, or a seized vial. Drug testing can still detect what you used.

In 2010, a lab found CJC-1295 in a seized vial with unknown contents [6]. Later tests found this drug family in human blood [9]. Another blood test skipped a slower step that uses a catcher protein [7]. A broad review found steady gains in sports testing [8].

In 2024, a test found small protein-like drugs, including CJC-1295 [13]. In 2025, another test searched urine for this drug family [14]. You won't get help with a health choice from those lab details. For you, the useful fact is simple: working sports tests exist.

How can sports tests find CJC-1295?

A sports lab first found CJC-1295 in a seized vial [6]. Newer tests search blood or urine for the same drug family. Tests from 2024-2025 handled small protein-like drugs [13] and urine samples [14]. You need to know they already work; they aren't ideas on paper.

Is CJC-1295 allowed in tested sport?

No. World Anti-Doping Agency rules bar CJC-1295 at all times [4]. The rule covers events and the time between them; the NCAA and other sports groups also forbid it. If a test finds the drug, your reason for taking it won't prevent a penalty.